Portfolio Solutions’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-85
Closed -$23K 43
2018
Q1
$23K Hold
85
﹤0.01% 96
2017
Q4
$27K Hold
85
﹤0.01% 84
2017
Q3
$27K Hold
85
﹤0.01% 85
2017
Q2
$23K Sell
85
-10
-11% -$2.64K ﹤0.01% 82
2017
Q1
$26K Buy
+95
New +$26.9K ﹤0.01% 76

Other funds holding BIIB

Portfolio Solutions's BIIB Position: Q2 2018 in Review

Portfolio Solutions sold out of Biogen (BIIB) in Q2 2018, closing a stake of 85 shares — an estimated $23K sold.

Portfolio Solutions first reported a position in BIIB in Q1 2017 and held it in 5 quarters. The position peaked at $27K in Q4 2017. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Portfolio Solutions reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Portfolio Solutions sold 85 Biogen shares in Q2 2018, an estimated $23K.
  • Portfolio Solutions first reported a position in Biogen in Q1 2017 and held it in 5 quarters.
  • Portfolio Solutions's Biogen position peaked at $27K in Q4 2017.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.